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Summary To evaluate the effects of airborne Aspergillus contamination during and after the
renovation work of a Florentine haematology unit, we conducted (November 2003–
January 2005) a strict programme of environmental fungal surveillance. Air samples
were taken from patients rooms, along the corridors inside the wards, along the corridor
between wards and outside the building. The concentration of Aspergillus fumigatus was
high along the corridor between the two haematology wards (2.98 CFU m)3), lower in
the non-neutropenic patients rooms and outside the hospital building (1.53 and
1.42 CFU m)3, respectively), very low in the neutropenic patients rooms
(0.09 CFU m)3). During this period, three proven cases (A. fumigatus), two probable
ones and two possible cases of invasive pulmonary aspergillosis were documented in 97
patients with acute leukaemia (7%). The three cases of proven aspergillosis coincided
with the period of renovation work and with the period in which we have found the
maximum concentration ofA. fumigatus along the corridor. These data suggest a possible
relationship between environmental fungal contamination and the incidence of invasive
aspergillosis, and underline the importance of environmental surveillance.
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Introduction
Invasive pulmonary aspergillosis (IPA) is a serious
infection arising prevalently in immunocompromised
patients where there is often a dramatic evolution due to
diagnostic and therapeutic difficulties.
The incidence of this disease has been increasing
dramatically in the last 30 years due to the increasingly
frequent use of immunosuppressive therapy, and is the
most common pulmonary mycosis in patients with
haematological malignancies.1–3
This infection comes about prevalently aerogenically
and Aspergillus fumigatus is the main aetiological agent;4
nevertheless the mycosis can also be caused by other
species such as Aspergillus flavus, Aspergillus niger,
Aspergillus terreus and so on.
These are environmental fungi isolated mainly in the
soil from decomposing vegetation, but also from air and
domestic dust. Therefore, it is possible that immuno-
compromised patients contract the infection in the
hospital setting as well.
Fungal contamination inside the hospital is the result
of a combination of various factors that are difficult to
investigate; however, different authors have established
that hospital infections caused by Aspergillus spp. occur
with greater frequency when construction work in
hospital wards is taking place or has just been
completed.5–9 This has been associated with the
increase of dust in the air, which facilitates the spread
of the fungal particles present.
In the period of September 2003–March 2004 major
renovation work was carried out in a Florentine
haematology unit, thus increasing the risk of fungal,
particularly Aspergillus, infections, mainly in patients
with acute leukaemia during severe neutropenia related
to aggressive chemotherapy.
The aim of this study was to monitor the fungal
burden for two purposes: (i) to highlight possible risk
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situations for patients; (ii) to correlate any Aspergillus
infections with the fungal burden.
Patients and methods
Patients
From November 2003 to January 2005, two haematol-
ogy wards on the first floor of a Florentine hospital were
monitored to make both a qualitative and quantitative
evaluation of fungal burden in the air. In this period, 115
haematologic patients were admitted to the wards, 97 of
whom (84%) were with acute myeloid leukaemia (AML)
or acute lymphoblastic leukaemia (ALL).
Patients with acute leukaemia, during the phase of
neutropenia, were allocated in one ward where the
rooms [multiple-bed rooms without high efficiency
particulate air (HEPA) filtration] had restricted access
to visitors and other particular behavioural measures: a
ban on opening windows and on plants or flowers,
measures adopted by the medical and nursing personnel
and visitors, such as masks, caps, shoe coverings, sterile
gloves and hand-washing.
In the other ward there were non-neutropenic
patients with haematological diseases allocated in
rooms that had neither restricted access nor particular
behavioural measures. All acute leukaemic patients
received an aggressive anti-neoplastic regimen for
remission–induction, consolidation or relapse ⁄ refrac-
tory disease and were examined to evaluate the
incidence of nosocomial infections. Neutropenia was
defined as absolute neutrophil count (ANC) less than
1000 cells ll)1 >10 days and severe neutropenia as
ANC < 100 cells ll)1. Fever was defined as a single
measurement >38.5 C on one occasion or >38 C on
two or more occasions within 12 h, not related to
underlying disease, chemotherapy or blood infusion.
The characteristics of patients with acute leukaemia
during the different phases of intensive chemotherapy,
and classification of febrile episodes are shown in
Table 1.
Standard antifungal prophylaxis was performed with
oral azoles (itraconazole 400 mg day)1) and stopped
when antifungal therapy was started. Febrile episodes
were classified according to EORTC criteria. The diag-
nosis of proven or probable or possible IPA was based on
clinical, radiographic and microbiological data accord-
ing to established criteria10: (i) clinical factors included
neutropenic patients (<500 neutrophils ll)1 for
>10 days); (ii) persistent fever despite broad-spectrum
antibacterial therapy; (iii) radiographic evidence
included plain radiography or a computed tomography
scan with the presence of a halo or an air-crescent sign;
(iv) microbiologic evidence, when available, was
reviewed and included culture and ⁄ or microscopic
evaluation (cytology or histopathology) or antigen, in
bronchoalveolar-lavage fluid (BAL), blood samples,
induced sputum, transbronchial biopsy, fine-needle
pulmonary aspirations and open lung biopsies.
Methods
Air samples were taken twice a month between 10:00
and 12:00 A.M. in at least one room of each ward, along
the corridors of the wards, along the corridor between
the wards and outside the building (270 total air
samples). To take the samples we used the Surface Air
Systems device (SAS; PBI International, Milan, Italy),
which allows direct impact of the air aspirated onto the
microbiological culture medium. For this study Sabou-
raud dextrose agar (Difco, Becton-Dickinson, Sparks,
Table 1 Clinical characteristics of the 97 patients with acute leu-
kaemia
Characteristics n Per cent
Age (years)
Mean 49
Range 17–77
Sex
Male 57 59
Female 40 41
Underlying disease
AML 84 87
ALL 13 13
CVC 74 76
Initial absolute neutrophil count (ANC)
<100 cells ll)1 37 38
100–500 cells ll)1 45 46
500–1000 cells ll)1 15 16
Days of neutropenia
Mean duration 15
Range 11–40
Status of underlying disease
Remission–induction 58 60
Consolidation 24 25
Relapse ⁄ Refractory 15 15
Prophylaxis
Antibacterial prophylaxis 89 91
Antifungal prophylaxis 84 87
Classification of febrile episodes
MDI 45 46
CDI 16 18
FUO 36 37
AML, acute myeloid leukaemia; ALL, acute lymphoblastic leu-
kaemia; MDI, microbiologically documented infections with and
without bacteraemia; CDI, clinically documented infections; FUO,
fever of undetermined origin; CVC, central venous catheter.
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MD, USA) mixed with chloramphenicol 0.05 mg ml)1,
penicillin 500 U ml)1 and streptomycin 0.5 mg ml)1
contained in contact type plates was used.
Two air samples were taken at every point examined,
one plate was incubated to 22 C to grow the total
mycotic flora and another plate was incubated to 37 C
to grow the thermophilic mycotic flora (especially
A. fumigatus and other Aspergillus species).
After 10 days of incubation, the colonies were
counted. Calculating the most probable number of
colony forming units (CFU) according to the conversion
table provided with the instrument, we reached the
concentration for m3 of air (X) with the following
formula: X = CFU · 1000 l)1 of air drawn.
Identification of the filamentous fungi was made
directly from the isolation media, on the basis of both
the macroscopic (colour, dimension, aspect) and micro-
scopic (fructification) characteristics of the colony. For
the yeasts no species identification was made. Compar-
ison of the quantitative data was made through
variance analysis.
Results
From November 2003 to January 2005 the mean total
fungal concentration (culture at 22 C) was signifi-
cantly higher outside the building (mean
323.55 CFU m)3) compared with the restricted access
rooms (52.74 CFU m)3, P < 0.001). Moreover, the
fungal burden was higher, although not significantly,
outside the building (mean 323.55 CFU m)3) in com-
parison with the corridors (mean 220.79 CFU m)3
along the corridors of the wards and 273.58 CFU m)3
along the corridor between the wards) and to the non-
restricted access rooms (194.31 CFU m)3) (Table 2).
Cladosporium was the most frequently isolated genus
(60.41% of the total isolated colonies), followed by
Penicillium (19.24%), Alternaria and other Dematiaceae
(2.8%), Aspergillus (2.27%), Paecilomyces (1.84%), other
hyphomycetes (13.44%), yeasts (1.65%).
In cultures at 37 C a lower total fungal concentra-
tion compared with that found in cultures at 22 C was
observed, but even at this temperature the scalarity of
the total fungal burden, which was the highest outside
and minimum inside the restricted access rooms, was
evident (Table 2). The Aspergillus genus was the most
isolated (33.8% of the total colonies) while other
hyphomycetes and yeasts (Dematiaceae, Mucoraceae,
Chrysonilia, Chrysosporium, Geotrichum, Penicillium,
Schizophyllum, Scopulariopsis, Trichoderma and so on)
were isolated occasionally. The Cladosporium genus was
never found.
The highest Aspergillus concentration was found
along the corridor between the two haematology wards
(10.32 CFU m)3), while low concentrations were
detected outside the building (3.93 CFU m)3), along
the corridors of the wards (3.04 CFU m)3) and in the
non-restricted access rooms (3.09 CFU m)3). Aspergillus
concentration was 0.53 CFU m)3 in the restricted
access rooms (with a highly significant difference
compared with the corridor between the wards,
P < 0.001) (Table 3).
Aspergillus niger was the most frequently isolated
species (35.08% of the total Aspergillus colonies),
followed by A. fumigatus (33.18%), A. flavus (7.85%),
Aspergillus nidulans (3.8%), A. terreus (2.3%), Aspergillus
clavatus (0.75%) and other species not identified
(17.04%).
Aspergillus niger and A. fumigatus were isolated
especially along the corridor between the wards
(3.97 CFU m)3 and 2.98 CFU m)3, respectively),
A. flavus along the corridors inside the wards
(1 CFU m)3). In the restricted access rooms, A. niger
and A. fumigatus (0.31 CFU m)3 and 0.09 CFU m)3,
respectively) were isolated rarely. Aspergillus flavus was
never found at this site (Table 3).
A. fumigatus was isolated in particular between
January and July 2004 (Table 4).
Table 2 Mean fungal concentration (CFU m)3) in haematology
wards and outside
Total fungal
concentration
(22 C)
Total fungal
concentration
(37 C)
Restricted access rooms 52.74 2.4
Non-restricted access rooms 194.31 7.9
Corridor inside the wards 220.79 11.2
Corridor between the wards 273.58 16.67
Outside 323.55 17.58
Table 3 Mean Aspergillus concentration (CFU m)3) in haematolo-
gy wards and outside (culture at 37 C)
Aspergillus
genus
Aspergillus
niger
Aspergillus
fumigatus
Aspergillus
flavus
Restricted access
rooms
0.53 0.31 0.09 0
Non-restricted access
rooms
3.09 1.09 1.53 0.11
Corridor inside
the wards
3.04 0.54 0.98 1.00
Corridor between
the wards
10.32 3.97 2.98 0.60
Outside 3.93 1.32 1.42 0.10
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This species was found mainly along the corridor
between the wards where it was isolated almost exclu-
sively in the period coinciding with or immediately after
the renovation work taking place between September
2003 and March 2004. There were positive samples
along the corridor inside the wards only in spring and
summer 2004. In the restricted access rooms, A. fumig-
atus was isolated only one time (spring 2004). In the
non-restricted access rooms it was found occasionally in
all seasons. Outside this species was isolated only four
times (in winter and summer 2004) (Table 4).
From November 2003 to January 2005, 15 atypical
lung infiltrates were observed in chest tomography in
patients with acute leukaemia. They were classified as
proven ⁄ suspected invasive fungal infections in seven
cases (7%), as shown in Table 5. All patients were
febrile and with severe neutropenia.
The three cases of proven aspergillosis took place in
the period of January–February 2004; the other cases
between March and December 2004 (Table 5).
Discussion
The data obtained during this study show that the total
fungal concentration (cultures at 22 and 37 C) tends
to increase from closed to open areas in the haematol-
ogy wards, reaching a maximum outside the building.
The low number of propagules found in the restricted
access rooms of the ward may be the result of the level
of environmental isolation (entrance limited to a min-
imum number of people, a ban on opening windows and
so on).
The use of a double incubation temperature (22  and
37 C) of the specimens allowed us to evaluate both the
total fungal concentration (to monitor the degree of
total fungal contamination) and the thermophilic
Table 4 Aspergillus fumigatus concentra-
tion (CFU m)3) in the haematology wards
and outside the hospital during the moni-
tored period
Monitoring
date Season
Restricted
access
rooms
Non-restricted
access
rooms
Corridor
inside the
wards
Corridor
between
the wards Outside
12 ⁄ 11 ⁄ 03* Autumn 03 0 0 0 0 0
27 ⁄ 11 ⁄ 03* 0 0 0 4.17 0
11 ⁄ 12 ⁄ 03* 0 0 0 0 0
14 ⁄ 01 ⁄ 04* Winter 03–04 0 0 0 8.33 0
28 ⁄ 01 ⁄ 04* 0 4.88 0 16.67 0
11 ⁄ 02 ⁄ 04* 0 0 0 0 3.38
25 ⁄ 02 ⁄ 04* 0 0 0 0 16.18
09 ⁄ 03 ⁄ 04* 0 0 0 0 0
23 ⁄ 03 ⁄ 04* Spring 04 0 0 0 8.33 0
06 ⁄ 04 ⁄ 04 0 0 4.00 0 0
05 ⁄ 05 ⁄ 04 0 12.58 0 4.17 0
19 ⁄ 05 ⁄ 04 1.99 0 4.17 8.33 0
09 ⁄ 06 ⁄ 04 0 0 4.17 0 0
30 ⁄ 06 ⁄ 04 Summer 04 0 3.57 0 0 6.65
07 ⁄ 07 ⁄ 04 0 0 8.33 0 3.58
10 ⁄ 09 ⁄ 04 0 0 0 0 0
22 ⁄ 09 ⁄ 04 Autumn 04 0 3.57 0 0 0
05 ⁄ 10 ⁄ 04 0 0 0 0 0
04 ⁄ 11 ⁄ 04 0 0 0 0 0
01 ⁄ 12 ⁄ 04 0 7.53 0 12.5 0
18 ⁄ 01 ⁄ 05 Winter 04–05 0 0 0 0 0
*In this period renovation work was in progress.
Table 5 Invasive pulmonary aspergillosis (IPA) cases during the
monitored period
Patient Leukaemia Diagnosis Date diagnosis Aetiology
1 ALL Proven
IPA
January 2004 Aspergillus
fumigatus
2 AML Proven
IPA
January 2004 A. fumigatus
3 AML Proven
IPA
February 2004 A. fumigatus
4 AML Possible
IPA
March 2004
5 AML Possible
IPA
April 2004
6 AML Probable
IPA
September 2004 Aspergillus spp.
7 AML Probable
IPA
December 2004 Aspergillus spp.
ALL, acute lymphoblastic leukaemia; AML, acute myeloid leu-
kaemia.
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mycotic flora concentration (to better highlight ther-
mophile species such as A. fumigatus and other Asper-
gillus species, which in a 22 C culture could be
inhibited by non-thermophile species, as Cladosporium
and Penicillium, that are extremely abundant in the air
or have a quicker growth rate).
The Aspergillus distribution in the different environ-
ments monitored does not seem to reflect what has been
observed for the total fungal burden. In fact, the
Aspergillus concentration within the building is, exclud-
ing the restricted access rooms, similar or greater than
that observed outside.
The greatest Aspergillus concentration was found
along the corridor between wards which was directly
connected to the construction zone. So the dust that
raised during the renovation, the humidity and tem-
perature of a heated environment (the work took place
in autumn–winter) may have contributed to the prolif-
eration of these thermophile species.
In the restricted access rooms the total mycotic
burden was always low and the Aspergillus burden was
even lower. Thus we might think that the level of
environmental isolation (entrance limited to a mini-
mum number of people, a ban on opening windows and
so on) was valid.
Aspergillus niger was the most frequently isolated
species, but there were no cases directly ascribable to
this species; the three case of certain aspergillosis were
all attributed to A. fumigatus.
The correlation between the concentration of
A. fumigatus in the air and cases of invasive aspergillosis
has been recognised by various authors.8,11,12 In partic-
ular, Arnow et al. [11] observed that the increase in the
mean concentration of A. fumigatus and A. flavus was
accompanied by a progressive increase in the incidence
of aspergillosis. In fact, they noticed that during a pre-
epidemic period the concentration of A. fumigatus and
A. flavus had been less than 0.01 and 0.2 CFU m)3,
respectively while in an epidemic period the concentra-
tion rose to 1.1 and 2.2 CFU m)3, respectively.
In our research, we found a high concentration of A.
fumigatus along the corridor between wards, especially
in the period coinciding with or immediately after the
renovation work. On this site the mean concentration of
A. fumigatus in the entire period observed (November
2003–January 2005) was 2.98 CFU m)3 but, if we
consider only the period November 2003–March 2004
(coinciding with the renovation work) and the two
following months (April–May 2004), this reaches
4.17 CFU m)3. Aspergillus fumigatus may have passed
from the corridor between wards to places strictly
contiguous such as the corridor inside the wards (mean
concentration 0.98 CFU m)3) and the rooms of non-
neutropenic patients without restricted access (mean
concentration of 1.53 CFU m)3). Before the neutrope-
nia phase related to chemotherapy, patients stay in
rooms without restricted access and use the corridors
inside and between the wards and thus may inhale
these micro-organisms in these locations. Indeed, in our
experience, the cases of proven aspergillosis coincide
with the period of renovation work and with the period
in which we have found the maximum concentration of
A. fumigatus in the corridor.
The possibility of a correlation between Aspergillus
concentration and cases of aspergillosis also seems to be
confirmed by our earlier published study.13 Indeed, in
the years 1999–2000, during research conducted in the
same haematology wards, we found extremely low
concentrations of A. fumigatus (0.09 CFU m)3 in the
rooms, 0.21 CFU m)3 along the corridors) and no case
of invasive aspergillosis was documented. Moreover, in
a previous clinical surveillance (unpublished data),
performed in the period 2001–2002 on the same
patient population (100 acute leukaemic patients) and
in the absence of building construction work, we
documented only two possible fungal pneumonias (2%).
In conclusion, this study suggests a possible relation-
ship between environmental fungal contamination in
haematologic patients and the incidence of invasive
aspergillosis, and also underlines the importance of
environmental surveillance.
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